RNA Exosomopathies

May 11, 2025

Researchers at Emory University and the University of Texas Health Science Centre have shown that mutations causing brain defects in humans also produce similar effects in budding yeast (Saccharomyces cerevisiae), a simpler eukaryotic organism.

What was discovered?

  • These mutations affect a cellular complex called the RNA exosome, which plays a critical role in RNA processing, surveillance, and degradation.
  • This reveals the potential to use yeast as a model organism for studying human neurological disorders, particularly those related to RNA exosome dysfunction.

What are RNA Exosomopathies?

  • RNA exosomopathies are disorders caused by mutations in genes coding for RNA exosome components.
  • These disorders primarily lead to brain maldevelopment, affecting structures like the pons and cerebellum.
  • A key example is Pontocerebellar Hypoplasia Type 1 (PCH1), which results in severe motor, cognitive, and developmental impairments in infants.

Role of the RNA Exosome

  • The RNA exosome is a multi-protein complex discovered in yeast in 1997.
  • It is responsible for:
    • Processing, surveillance, and degradation of different types of RNA molecules.
    • Maturation of ribosomal RNA (rRNA) – essential for building ribosomes.
    • Elimination of faulty messenger RNA (mRNA) and regulation of non-coding RNAs (ncRNA).

Experimental Findings (Study 1 – Journal RNA)

  • Researchers introduced human disease mutations into corresponding yeast genes.
  • Found defects in:
    • RNA surveillance
    • Ribosome production
    • Protein synthesis
  • Each mutation had a distinct molecular signature, explaining the varied clinical symptoms in patients.

 Creation of a Humanised Yeast Model (Study 2 – Journal G3)

  • Scientists replaced segments of yeast RNA exosomes with human or mouse genes.
  • Of 9 core proteins, 6 were successfully replaced, with 3 supporting normal yeast growth.
  • Introduced known brain-defect mutations into this model.
  • Proved that mutations directly impair RNA exosome function and are not mediated through indirect processes.

Why Yeast?

  • Yeast is a simple eukaryote, easy to genetically modify and culture.
  • Offers a cost-effective and fast method for testing hypotheses and potential drug interventions.
  • Using yeast models allows rapid screening of RNA exosome mutations and their functional consequences.

Latest Current Affairs

See All

Enquire Now